FDA gives on Thursday a public warning to health advisory pregnant and doctors about a bad risk of fetal cardiac defects in it antidepressant generic paxil of Glaxo Smith Kline – in general as a paroxetine famously – during the first three months of the gestation which Washington Post reports (Kaufman / Vedantam, Washington Post, 09:12). The moves Paxil warning of the category D, FDA, the second-highest category for risk of birth defects. Category D means that either “inspected, or observation studies’ examinations of pregnant women” have shown a risk for the fetus “(FDA release 8.12). The consultation procedure is on temporary results from studies after which Mrs. Paxil two under the first three months of the gestation been found based 1.5 to Sun probably twice in the child birth of a child with a cardiac defect as the other women who took antidepressants or none gives everybody (Washington Post, 09:12).
Studies, recommendations
The first study, a judgment of the U.S. insurers sick person’s data proved that about 2% of the women, took generic paxil early in the gestation bore infants with cardiac defects, on about 1% of all women in the comparison. The other study which proved data of about 6.900 children in Sweden that 1.5% of the women in her first trimester under Paxil bore infants with a cardiac defect examines, in comparison to 1% of the women, the antidepressants other (RichWin, Reuters, 12 took / 8). Most can to cardiac defects reported in the studies became atrium and ventricular septal defect, or holes in the cardiac wall, sometimes inevitably operation and sometimes is able to do without treatment (AP / South Florida Sun-Sentinel, 09:12) solve. For the women, Paxil who become pregnant or are pregnant in the third month or less flat, “[h] ealth members had to go to be delivered [the drug] – and trans position to another antidepressant, if given,” FDA said in a press release and added, “with some patients who can be bigger than the advantages of generic paxil furthermore potential risk for the fetus. FDA is the consultation in the public health not to Paxil with women who are during the first three months of the gestation or plan a gestation to prescribe, unless, another treatment options are not adequate (FDA released 8.12). Before discussing on Thursday to ones Paxil had report, 9 / 28) as a drug of the category C for the pregnant women who were classified comprehensive studies of her effects during the gestation meant not carried out (emperor Daily Women’s Health Policy.
Reaction
GSK Speaker Gaile kidney said that even the studies are examinations of data banks, and not clinical studies (Reuters, 8.12). She added that examines the enterprise to see and why as generic paxil could cause no birth defects (Washington Post, 09:12). GSK has with the FDA together, around the marking changes and carry out, around the updated results for Paxil doctors and patients communicate Thus the treatment well informs decisions can hit, “Jack model, GSK vice president of the clinical psychiatrics, said (GSK release 8.12). Kimberly Yonkers, to a psychiatrist in the Yale University School of Medicine, then took the margins of both studies, added: “Depression is still undertreated. Pregnant women in particular are immense undertreated, and you worries about themselves to person wrongfully fear. “Robert Temple, FDA manager for medical politics, said:” If you are on Paxil and pregnant, our consultation is to be spoken to your doctor and consider change-over another drug, “and added,” sudden setting down of Paxil has his own problems, but the clear recommendation here is that you maybe think about a change “(Washington Post, 09:12).
Glaxo Smith Kline, to the manufacturer of the antidepressant, generic paxil, have warned, that to raise the drug the risk of suicide experiments with people less than 30 years. Glaxo has sent a letter to doctors claim this.
According to a clinical study, from 3455 people less than 11 Paxil tried to kill itself. Under the placebo group of 1978 people, one tried to commit suicide. Most suicide experiments were made by the patients less than 30 years. One of the patients, the suicide generic paxil succeeded it tried.
Mary Anne Rhyne who works for Glaxo said, the enterprise is to be supervised the consultation of doctors for all patients to make sure that her symptoms Do Not make worse, while they are under Paxil.
The FDA says, doctors and patients had to do the present advice to follow. The agency is still of the analysis of the results of the study.
A speaker of the FDA said, it is important, patients that generic paxil not suddenly produce the intake of drugs without previous consultation with her doctor.

